Anish Maskey | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed

 

Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

PhD Student at University of Medicine and Pharmacy of Craiova, Romania

Mohamed-Zakaria Assani is a dedicated and academically accomplished medical professional from Craiova, Romania. A graduate of the University of Medicine and Pharmacy of Craiova with a Doctor of Medicine degree, he is currently pursuing a PhD in Immunology, focusing on the implications of inflammation and atherosclerosis in chronic kidney disease. His academic excellence is reflected in his high GPAs and his master’s dissertation on population exposure to ionizing radiation. Mohamed-Zakaria has demonstrated leadership and community engagement through roles such as Project Coordinator for ONCOHELP and active volunteer work within student medical societies. He has participated in numerous congresses and clinical workshops, enhancing his practical and theoretical knowledge. Proficient in English and skilled in digital tools, he is well-equipped for research communication and collaboration. With a strong foundation in clinical research and a growing academic profile, he stands out as a promising early-career researcher committed to advancing medical science.

Professional Profile

ORCID Profile

Education

Mohamed-Zakaria Assani has an impressive academic background rooted in medical sciences. He graduated with a Doctor of Medicine (MD) degree from the University of Medicine and Pharmacy of Craiova, achieving an outstanding overall GPA of 9.69 and a dissertation exam GPA of 9.92. His academic excellence dates back to high school, where he earned a Baccalaureate GPA of 9.50 from the National College Frații Buzești in Craiova. Currently, he is pursuing a PhD in Immunology at the same university, where his research explores the interplay between inflammation, atherosclerosis, and chronic kidney disease—an area of critical importance in modern healthcare. His educational journey demonstrates consistent high performance, intellectual curiosity, and a solid foundation in both theoretical and practical aspects of medicine. He has also earned English language certifications (C1 level), further supporting his ability to engage with international research communities and access global academic resources effectively.

Professional Experience

Mohamed-Zakaria Assani has gained practical medical and leadership experience through a series of impactful roles. Currently, he serves as a resident in Laboratory Medicine at Filantropia Clinical Hospital and the Clinical Hospital of Neuropsychiatry in Craiova. These roles have enabled him to develop core diagnostic and analytical skills essential for laboratory-based and clinical research. Earlier in his academic journey, he demonstrated initiative and community engagement as a project coordinator for ONCOHELP within SSM Craiova and as a volunteer for various student-led projects, including TRANSMED and university-wide events such as the Freshman Ball. His participation in medical workshops and congresses—like the Annual Congress of Surgery for Students and CIMSC—further underscores his dedication to continuous professional development. These experiences have not only broadened his clinical perspective but also allowed him to build strong interpersonal and organizational skills, both crucial for team-based medical research and healthcare practice.

Research Interest

Mohamed-Zakaria Assani’s research interests lie at the intersection of immunology, cardiovascular pathology, and nephrology, focusing specifically on how inflammation and atherosclerosis contribute to chronic kidney disease (CKD). This multidisciplinary approach highlights his commitment to understanding complex disease mechanisms and improving patient outcomes through evidence-based research. His PhD work delves into the cellular and molecular pathways that drive disease progression in CKD, a pressing global health challenge. Additionally, his master’s dissertation explored population exposure to ionizing radiation from high-performance radiological investigations, demonstrating his early concern for public health and medical safety. Mohamed-Zakaria is driven by a desire to bridge laboratory findings with clinical applications, and his work holds the potential to inform diagnostic tools, therapeutic strategies, and preventive measures. His research aims not only to contribute new knowledge to the scientific community but also to enhance clinical practice, particularly in the management of chronic and systemic diseases.

Award and Honor

Although specific formal awards are not listed, Mohamed-Zakaria Assani’s academic record and extracurricular achievements position him as a strong candidate for recognition in research and leadership. Graduating with distinction from both high school and medical school, and earning high scores on his dissertation, he has consistently demonstrated academic excellence. His selection as a Project Coordinator within SSM Craiova for the ONCOHELP initiative, along with his active participation in prestigious student congresses such as CIMSC and the Annual Congress of Surgery, reflects peer and institutional acknowledgment of his capabilities. He also holds English proficiency certifications (Cambridge C1), further validating his readiness for international academic participation. His combination of scholarly commitment, volunteer service, and leadership roles speaks to a well-rounded and motivated individual deserving of early-career honors, such as young researcher awards or medical innovation fellowships. His profile illustrates promise and preparedness for future accolades in the field of medical research.

Conclusion

In conclusion, Mohamed-Zakaria Assani is a highly motivated and capable early-career medical researcher with a commendable blend of academic achievement, clinical experience, and leadership involvement. His educational accomplishments and current doctoral work in immunology place him at the forefront of critical research on chronic kidney disease. He has proactively contributed to both academic and volunteer communities, showing a strong sense of responsibility and dedication to healthcare. While he would benefit from expanding his research portfolio through publications and international collaborations, his foundational strengths are undeniable. With a clear focus on impactful, multidisciplinary research and a history of academic excellence, he is exceptionally well-positioned to contribute to the future of medical science. He is a promising candidate for research awards and a strong example of emerging talent in laboratory and clinical medicine. His continued progress will no doubt lead to significant contributions in the medical and scientific fields.

Publications Top Notes

1. Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients

  • Authors: Roxana-Viorela Ahrițculesei, Lidia Boldeanu, Daniel Cosmin Caragea, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Anca Marilena Ungureanu, Constantin Cristian Văduva, Anda Lorena Dijmărescu, Alin Iulian Silviu Popescu, et al.

  • Year: 2025

  • Citation: Ahrițculesei, R.-V., Boldeanu, L., Caragea, D. C., Vladu, M., Clenciu, D., Mitrea, A., Ungureanu, A. M., Văduva, C. C., Dijmărescu, A. L., Popescu, A. I. S., et al. (2025). Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients. International Journal of Molecular Sciences, 26(8), 3661. https://doi.org/10.3390/ijms26083661

2. Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy

  • Authors: Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Constantin Cristian Văduva, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Roxana-Viorela Ahrițculesei, Alexandra-Ștefania Stroe-Ionescu, Alexandru-Dan Assani, et al.

  • Year: 2025

  • Citation: Assani, M.-Z., Novac, M. B., Dijmărescu, A. L., Văduva, C. C., Vladu, M., Clenciu, D., Mitrea, A., Ahrițculesei, R.-V., Stroe-Ionescu, A.-Ș., Assani, A.-D., et al. (2025). Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy. Nutrients, 17(8), 1339. https://doi.org/10.3390/nu17081339

3. Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania

  • Authors: I. Prejbeanu, M. Z. Assani, F. Niculescu, L. A. Prunariu, R. G. Prejbeanu

  • Year: 2024

  • Citation: Prejbeanu, I., Assani, M. Z., Niculescu, F., Prunariu, L. A., & Prejbeanu, R. G. (2024). Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania. European Journal of Public Health, 34(Supplement 1), ckae144.2140. https://doi.org/10.1093/eurpub/ckae144.2140

Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

Posted on by World Top Scientists

Dr. Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

MD at Izmir City Hospital, Turkey

Dr. Tuba Yüce İnel is a dedicated physician and researcher specializing in internal medicine, immunology, and rheumatology. With extensive experience in clinical practice and academic research, she has contributed significantly to the study of autoimmune diseases, inflammatory conditions, and rheumatological disorders. Her research focuses on understanding disease mechanisms and improving treatment approaches for complex conditions such as systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. Dr. İnel has published multiple papers in high-impact international journals, providing valuable insights into disease management and patient outcomes. Actively involved in scientific collaborations, she has participated in various national research projects aimed at advancing rheumatological medicine. She has also been recognized for her contributions with prestigious awards, highlighting her expertise and commitment to medical science.

Professional Profile

Education

Dr. Tuba Yüce İnel began her medical education at Hacettepe University School of Medicine, where she earned her Bachelor’s degree in Medicine in 2012. She then pursued a specialization in internal medicine at Istanbul University Faculty of Medicine, completing her training in 2017 with a thesis on the side effects of immunosuppressive treatments in primary glomerular diseases. Her academic journey continued with a minor specialization in Immunology and Rheumatology at Dokuz Eylül University, where she completed her training in 2022. Through her education at leading Turkish medical institutions, Dr. İnel gained extensive clinical expertise and research experience, shaping her career in autoimmune and inflammatory diseases.

Professional Experience

Dr. İnel has held key positions as a Research Assistant at both Istanbul University (2012-2017) and Dokuz Eylül University (2018-present), where she has contributed to research and medical education. She has played a significant role in clinical studies related to autoimmune diseases, particularly focusing on systemic sclerosis and inflammatory pathways. Additionally, she has been actively involved in teaching and mentoring medical students and residents, sharing her expertise in rheumatology and immunology. Her professional journey includes participation in several government-funded scientific research projects, further solidifying her role as a leading researcher in rheumatology.

Research Interests

Dr. İnel’s research focuses on autoimmune diseases, inflammatory rheumatologic disorders, and immunology, with a particular emphasis on systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. She has explored the role of immune pathways, including the NEK7-NLRP3 inflammasome pathway, in disease progression and treatment response. Her studies on plasma arginine-citrulline levels in systemic sclerosis have contributed to understanding disease severity and malabsorption mechanisms. Additionally, her research on obesity’s impact on ankylosing spondylitis treatment has provided real-world data on therapeutic outcomes. She continues to investigate novel biomarkers and targeted treatments to improve patient care and enhance therapeutic strategies in rheumatology.

Awards and Honors

Dr. İnel’s outstanding research has earned her recognition and accolades within the medical community. In 2022, she won the First Prize for Oral Presentation in Spondyloarthritis, awarded by the Turkish Rheumatology Association, highlighting her excellence in presenting groundbreaking research. Her work has been published in internationally recognized journals, showcasing her significant contributions to rheumatology and immunology. She is also an active member of the Turkish Rheumatology Association, reflecting her commitment to advancing knowledge and collaboration in her field. Through her academic achievements, research excellence, and clinical expertise, Dr. İnel continues to establish herself as a leading figure in rheumatology research.

Conclusion

Dr. Tuba Yüce İnel is a strong candidate for the Best Researcher Award due to her academic achievements, impactful research in rheumatology, national recognition, and continuous contributions to scientific literature. If she enhances international collaborations, takes leadership roles in research projects, and secures external funding, her candidacy would become even more compelling.

Publications Top Noted

1. A Life-Threatening Manifestation of Granulomatosis with Polyangiitis: Subglottic Stenosis

  • Authors: Yüce-İnel, T., Uslu, S.
  • Year: 2024
  • Journal: Archives of Rheumatology
  • Citations: 0

2. Assessing Safety and Efficacy of TNFi Treatment in Late-Onset Ankylosing Spondylitis: A TURKBIO Registry Study

  • Authors: Uslu, S., Gülle, S., Sen, G., Akkoç, N., Onen, F., Yüce-İnel, T.
  • Year: 2024
  • Journal: Scientific Reports
  • Citations: 4

 

Assoc Prof Dr Przemyslaw Zdziarski | Clinical immunology | Best Researcher Award

Posted on by World Top Scientists

Assoc Prof. Dr Przemyslaw Zdziarski | Clinical immunology | Best Researcher Award

M.D, 1.Lower Silesian Center 2. Private Research Institute of Nature, Poland

Dr. Przemysław Zdziarski is an accomplished M.D., Ph.D., and habilitated doctor in the field of medicine, specializing in clinical immunology and infectious diseases. He graduated from the Military Medical Academy in 1996 and went on to receive a Ph.D. in medicine in 2002 for his groundbreaking research on drug hypersensitivity. Over the years, Dr. Zdziarski has made significant contributions to interdisciplinary translational medicine, collaborating with leading institutions such as the Hirszfeld Institute of Immunology and Experimental Therapy, and the Military Institute of Engineering Technology. He currently practices as a senior specialist at the Lower Silesian Oncology, Pulmonology & Hematology Center. His research areas include immunodeficiencies, immunotherapy, inflammatory adverse drug reactions, microbiome research, and oncology. He has authored over 40 publications and holds multiple patents for mobile water filtration technology. Dr. Zdziarski has earned multiple awards and distinctions for his innovative work in immunology and clinical research.

Profile 

Strengths for the Award:

Extensive and Diverse Research Background: Dr. Zdziarski’s career has spanned over two decades of significant contributions to medicine, with a focus on immunology, infectious diseases, and translational research. His work is characterized by a multidisciplinary approach, merging immunology, microbiome research, and clinical immunology to address key healthcare challenges. His research interests cover a broad spectrum, including immunodeficiencies, opportunistic infections, adverse drug reactions, vaccines, oncogenesis, and immunotherapy.

  1. Highly Productive Researcher: Dr. Zdziarski is the first author of over 40 peer-reviewed publications, many of which have made substantial contributions to the fields of immunology, infectious diseases, and pharmacovigilance. His work has been widely cited, and his papers have been recognized in leading journals. The research on immunoglobulin-induced anaphylaxis, T-cell responses, and microbiome impacts on immunotherapy, particularly in cancer and COVID-19, underscores his capacity to address emerging and critical clinical issues.
  2. Awards and Recognition: Dr. Zdziarski has received numerous awards, both for his scientific and organizational contributions. Notably, his distinctions at major international congresses (e.g., the European and World Congress of Immunology) and recognition for his work on immunomodulation in rare diseases, passive blood anaphylaxis, and the role of microbiome in disease progression highlight the high impact of his work. His scientific achievements have earned him awards at conferences in Stockholm, Berlin, and Montreal, which speak to the quality and innovation of his research.
  3. Collaborative and Interdisciplinary Approach: Dr. Zdziarski has a proven record of successful collaboration with top scientific institutions, such as the Hirszfeld Institute of Immunology, the Military Institute of Engineer Technology (WITI), and the Lower Silesian Oncology, Pulmonology & Hematology Center. His ability to work with interdisciplinary teams—combining expertise in microbiology, immunology, and clinical medicine—enables him to advance research with direct applications to clinical practice.
  4. Innovative Contributions: Beyond traditional research, Dr. Zdziarski has contributed to technological innovation, with two patents and a utility model related to mobile water filters for military and humanitarian use, demonstrating his ability to translate scientific discoveries into real-world applications.
  5. Mentorship and Leadership: As a senior specialist and consultant, Dr. Zdziarski has played a key role in shaping clinical practice and research at several institutions. His leadership in the Hospital Infections Control Team and his role as a consultant for the Polish Armed Forces and the Hirszfeld Institute of Immunology further demonstrate his influence on public health and academic development.

Areas for Improvement

  1. Broader Recognition in Clinical Immunology: While Dr. Zdziarski is well-recognized in academic circles and has contributed significantly to research in immunology and infectious diseases, there is room for further outreach to clinical practitioners, especially in the integration of his research on the microbiome and immunotherapy into daily clinical practice. Greater dissemination of his findings to the broader medical community could improve clinical outcomes.
  2. Greater Focus on Translational Impact: While Dr. Zdziarski’s work has been highly influential in academic settings, it could be beneficial to place more emphasis on the long-term translational impact of his research. Continued work to bridge the gap between laboratory findings and real-world clinical applications will solidify his position as a leader in clinical translational medicine.
  3. Diversification of Funding Sources: While Dr. Zdziarski has been involved in several prestigious collaborations, pursuing additional funding from diverse sources, such as private sector partnerships or international research foundations, could expand the scope of his work and its clinical applications.

Education 

Dr. Przemysław Zdziarski completed his medical education at the Military Medical Academy in Łódź, Poland, earning his M.D. in 1996. He further pursued research, obtaining a Ph.D. in 2002 from the same institution for his work on drug hypersensitivity. In 2003, he became a certified Infectious Disease Specialist after completing his specialization. Dr. Zdziarski continued his clinical training in clinical immunology, receiving a specialist title in 2006 after training at the Lower Silesian Center for Cellular Transplantation and the Hirszfeld Institute of Immunology and Experimental Therapy in Wrocław. In 2023, he earned his habilitation degree (post-doctoral degree) in medicine for his research on the human microbiome. Throughout his education, Dr. Zdziarski has received numerous distinctions for his academic achievements and contributions to scientific advancement. His continuous commitment to improving clinical and immunological research underscores his expertise in the medical field.

Research Focus

Dr. Przemysław Zdziarski’s research focuses on immunodeficiencies, opportunistic infections, and inflammatory adverse drug reactions. His interdisciplinary approach spans translational medicine, taking innovative scientific findings from the laboratory to real-world clinical applications. Notably, Dr. Zdziarski has contributed significantly to the field of immunotherapy, especially in the context of rare diseases and drug-induced complications. He has also expanded his research to include the human microbiome, exploring its role in various diseases and its interaction with immunological therapies. His work on drug hypersensitivity and drug-induced immune reactions has resulted in significant advances in pharmacovigilance and immunological diagnostics. Dr. Zdziarski is also an expert in oncology, with particular interest in immunooncology, and has contributed to understanding the immunological basis of tumor biology. His collaborative research across various institutions underscores his commitment to multidisciplinary approaches in advancing precision medicine.

Selected Publications 

  • Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency 🩸💉
  • Overuse of high stability antibiotics and its consequences in public and environmental health 🌍💊
  • Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency 🦠🦷
  • A case of stiff person syndrome: immunomodulatory effect of benzodiazepines: successful rituximab and tizanidine therapy 💊🧠
  • Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles 🌿🔬
  • Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency 🧬💉
  • A case report of lymphoid interstitial pneumonia in common variable immunodeficiency 🫁💥
  • CMV-specific immune response—New patients, new insight: Central role of specific IgG during infancy and long-lasting immune deficiency after allogenic stem cell transplantation 🧫🧬
  • Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 🦠🧓
  • Microbiome Analysis and Pharmacovigilance After Inhaled Glucocorticoid: Oral Dysbiosis With the Isolation of Three Rothia Species and Subsequent Sjögren’s Syndrome Development 🔬🦠

Conclusion

Dr. Przemysław Zdziarski is a highly deserving candidate for the Best Researcher Award. His outstanding scientific achievements, impactful contributions to clinical immunology and microbiome research, and his ability to innovate in healthcare technologies make him an exemplary candidate. His work has already had a significant impact on the fields of immunodeficiencies, immunotherapy, and infectious diseases. With further focus on translational research and clinical outreach, Dr. Zdziarski’s future contributions have the potential to transform medical practice, especially in the domains of precision medicine and immune-related therapies. His leadership, productivity, and commitment to scientific advancement make him an invaluable asset to the global research community.